Dr. Amrit Ray, global president, R&D and Medical, Upjohn Division, Pfizer Inc., offers his thoughts about the COVID-19 pandemic and how to best protect yourself and your family.
medical
ASA to Cosponsor AI in Clinical Drug Development Symposium in May
The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.
Diagnosing and Treating Noncommunicable Diseases Around the World
Kelly H. Zou, Jim Z. Li, and Nik Sethi of the Upjohn Division of Pfizer Inc. taught a three-part web-based lecture on generating and harnessing real-world evidence, health information technology, and artificial intelligence. Here, Richard Zink from the Biopharmaceutical Section asks the lecturers a few follow-up questions.
Survey of Publications Generated by ClinicalStudyDataRequest Consortium
Access to clinical trial data provides opportunities to conduct further research that can help advance medical science or improve patient care.
Significance Spotlights Arithmetic Mean in December Issue
The December 2017 issue of Significance is now available in print and digital formats. The cover story tells the history of the arithmetic mean.
Medical Devices and Diagnostics Section News for October 2017
The Medical Devices and Diagnostics Section is sponsoring a student paper competition to offset travel costs to JSM 2018.
Medical Devices and Diagnostics Newest ASA Section
SIGMEDD, the Statistical Interest Group for Medical Devices and Diagnostics, has officially become the Medical Devices and Diagnostics Section (MDD) of the American Statistical Association.